Effect of losartan on slowing progression of chronic allograft nephropathy

Chinese Medical Sciences Journal

Volumn 20, Issue 4, 2005, Pages 231-236

  Wang, Ping Xian ^a   Fan, Ming Qi ^a   Huang, Chi Bing ^a   Feng, Jia Yu ^a   Xiao, Ya ^a   Fang, Zhen Qiang ^a   Zhang, Yin Pu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Kidney transplantation; Losartan; Nephropathy; Transforming growth factor beta1

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; HLA ANTIGEN; LOSARTAN; LYMPHOCYTE ANTIBODY; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POLYCLONAL ANTIBODY; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HISTOLOGY; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CREATININE; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LOSARTAN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 30444441789     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chkhotua A, Shohat M, Tobar A, et al. Replicative senescence in organ transplantation-mechanisms and significance. Transpl Immunol 2002;9:165-71.
2. Hesselink DA, Smak PJ, Weimar W. The use of cyclosporine in renal transplantation. Transplant Proc 2004;369:S99-S106.
3. Montanaro D, Gropuzzo M, Tulissi P, et al. Renal allograft protection with early angiotensin converting enzyme inhibitors administration. Transplant Proc 2004;36:692-4.
4. Grandaliano G, Dipaolo S, Monno R, et al. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the rob of coagulation and fibrinolysis in renal graft fibrosis. Transplantation 2001;72:1437-43.
5. Campistol JM, Inigo P, Jimenez W, et al. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy. Kidney Int 1999;56:714-9.
6. Campistol JM, Inigo P, Larios S, et al. Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy. Nephrol Dial Transplant 2001;16:114-6.
7. Sijpkens YW, Bruijn JA, Paul LC. Chronic allograft nephropathy categorised in chronic interstitial and vascular rejection. Transplant Proc 2001;33:1153-9.
8. Lin J, Valeri AM, Markowitz GS, et al. Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation 2002;73:783-8.
9. Wang PX, Zhang YP, Huang CB, et al. Immunosuppressive regimens in patients with chronic allograft nephropathy. Di 3 Jun Yi Da Xue Xue Bao 2002;24:1460-1.
10. Cuhaci B, Kumar MS, Bloom RD. Transforming growth factor-beta levels in human allograft chronic fibrosis correlate with rate of decline in renal function. Transplantation 1999;68:785-90.
11. Krieger NR, Becker BN, Heisey DM, et al. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation 2003;75:1677-82.
12. Viklicky O, Matl I, Voska L, et al. TGF-beta1 expression and chronic allograft nephropathy in protocol kidney graft biopsy. Physiol Res 2003;52:353-60.
13. Zhao J, Jia LS, Chen DY, et al. Adenovirus-mediated TGF-beta1 gene transfer to human degenerative lumbar intervertebral disc cells. Chin Med J 2002;115:409-12.
14. Grandaliano G, Di-Paolo S, Monno R, et al. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis. Transplantation 2001;72:1437-43.
15. Ahmed A, Huang L, Raftery AT, et al. Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia. Transplantation 2004;77:686-92.
16. Dikow R, Zeier M, Ritz E. Hypertension after renal transplantation. Minerva Urol Nefrol 2003;55:101-9.